Discover a breakthrough in preventing therapy-related clonal hematopoiesis & myeloid neoplasms with CDK4/6 inhibitors. #WashingtonUniversity 's latest patent application #US20240108625A1 could change the game. #HealthInnovation #CDK46Inhibitors #CancerPrevention #medicine
Very interesting trial, finally in its final version! Check it out!
#solti #academicresearch #breastcancer #cdk46inhibitors
Learn about #CDK46Inhibitors , how they stop #BreastCancer growth, and find out what trials Dana-Farber physicians, Erica Mayer Harold J. Burstein, MD, PhD, FASCO Ada Waks and Rachel Freedman, MD, MPH, are currently leading.
👉blog.dana-farber.org/insight/2018/0…
Great slide from Dr. Williams on managing side effects of new treatments for #metastaticbreastcancer at the #LBBCMetsConf #CDK46Inhibitors #Interventions
📄Special Report just published by Drs. Ilana Schlam (Ilana Schlam), Antonio Giordano (@antgiorda) & Sara Tolaney (@stolaney1) on Interstitial lung disease and #CDK46 inhibitors in the treatment of #BreastCancer .
Read it here⬇️⬇️
pubmed.ncbi.nlm.nih.gov/37994878/ #CDK46 Inhibitors #bcsm
Join our Live-Webinar 'The Changing Treatment Landscape of CDK4/6 Inhibitors: Moving from late to early stages' on 09 May 2022, 6 pm CET.
Register here: universimed.com/CDK4/6_Inhibit… #breastcancer #cdk46inhibitors #academicresearch #metastaticbreastcancer #medicalwebinar #fortbildung
SO grateful and happy to present and share experiences from our #implementation journey with #digital follow-up with #epro from Elekta Kaiku as routine cancer care for all our pts on #immunotherapy , #egfr , #alk , #tki and #cdk46inhibitors @healthresearchconference23 in Stavanger!
Register now universimed.com/CDK4/6_Inhibit… for the live webinar on 09 May 2022, 6.00 pm CET and learn more about The Changing Treatment Landscape of CDK4/6 Inhibitors in #breastcancer
#cdk46inhibitors #abcsg #novartis #universimed #CancerResearch #brustkrebs forschung #brustkrebs
Guardant Health Announces Collaboration With AstraZeneca to Develop Companion Diagnostic to Identify Patients With ESR1-mutated Metastatic Breast Cancer
trialstat.com/2022/12/guarda…
#AstraZeneca #BreastCancer #CDK46Inhibitors #ClinicalResearch
Interesting paper in JAMA Oncology Another example of drug pharmacology with a wide prescribed drug (PPI) that can affect palbociclib efficacy in Breast Cancer patients…
#breastcancer #CDK46inhibitors
jamanetwork.com/journals/jaman…
Informative review article - Novel targeted therapies for #metastaticbreastcancer .
atm.amegroups.com/article/view/3…
#BCAM #breastcancer #science #science advances #stage4 #targetedtherapy #CDK46inhibitors
Dr. Sylvia Adams is director of the breast cancer center at NYU Langone Health's Perlmutter Cancer Center at NYU Langone Health #breastcancer #CDK46inhibitors obroncology.com/video/adjuvant…
New Drug Shows Promise in Overcoming Resistance to CDK4/6 Inhibitors in Breast Cancer
be-inlite.com/new-drug-shows…
#CDK46inhibitors #RANKprotein #Resistancemechanisms #Denosumab #Breastcancertreatment